OIP5 and neoplasm: OIP5‐AS1 was also upregulated in doxorubicin‐resistant cells in chemo‐resistant patients, and its depletion decreased doxorubicin resistance and tumour cell proliferation, coupled with increased tumour cell apoptosis and better chemotherapy success as measured by tumour weight and volume.125